BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2025 10:38:30 AM | Browse: 14 | Download: 147
 |
Received |
|
2025-02-05 03:58 |
|
Peer-Review Started |
|
2025-02-05 03:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-18 07:38 |
|
Revised |
|
2025-03-04 01:48 |
|
Second Decision |
|
2025-04-14 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-04-14 09:40 |
|
Articles in Press |
|
2025-04-14 09:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-06-06 07:57 |
|
Publish the Manuscript Online |
|
2025-06-16 10:38 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Evidence Review |
| Article Title |
Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rahiya Rehman |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rahiya Rehman, Assistant Professor, MD, Department of Pediatric Gastroenterology, Saint Louis University, 1465 S Grand Blvd, Saint Louis, MO 63108, United States. rahiya.rehman@health.slu.edu |
| Key Words |
Pediatrics; Obesity; Metabolic dysfunction-associated steatotic liver disease; Glucagon-like peptide-1; Glucagon like peptide |
| Core Tip |
Understanding the impact of glucagon-like peptide-1 analogs in the pediatric population is crucial, as these medications have the potential to address a significant treatment gap in childhood metabolic disorders. Their effects on weight regulation, insulin sensitivity, and liver health could offer long-term benefits, particularly in conditions such as obesity, type 2 diabetes, and metabolic dysfunction associated steatotic liver disease. Further research and clinical trials are needed to establish their safety, efficacy, and appropriate use in children. |
| Publish Date |
2025-06-16 10:38 |
| Citation |
<p>Rehman R. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. <i>World J Clin Pediatr</i> 2025; 14(3): 105731</p> |
| URL |
https://www.wjgnet.com/2219-2808/full/v14/i3/105731.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v14.i3.105731 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
